Max Health stock: At INR 846.00, Max Health stock sits 0.47 percent above its 52-week low

Published on 10/16/2026 at 18:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Max Health stock was INR 846.00 on October 16, 2026, down 1.40 percent on NSE. Fiscal 2026 revenue reached INR 83.73 billion, up 19.1 percent.

Stock nears its yearly low

Max Health stock stood 0.47 percent above its 52-week low on October 16, 2026.
Revenue in fiscal year 2026 reached INR 83.73 billion, up 19.1 percent year over year.
Max Health stock stood at INR 846.00 on October 16, 2026 at 3:29 p.m. IST, down 1.40 percent versus the NSE prior close of INR 858.00.
Market capitalization was INR 823.4 billion and the P/E ratio was 56.74 on October 16, 2026.

Max Health, INE027H01010, Illustration mit AI erstellt.

At INR 846.00, Max Health (INE027H01010) stood 0.47 percent above its 52-week low on October 16, 2026. The next quarterly results are scheduled for October 30, 2026, according to finanzen.ch. Max Health stood at INR 846.00 on the NSE on October 16, 2026 at 3:29 p.m. IST, down 1.40 percent from the INR 858.00 prior close.

Fiscal 2026 revenue reached INR 83.73 billion

Revenue in fiscal year 2026 reached INR 83.73 billion, up 19.1 percent from fiscal year 2025, while net profit came to INR 14.42 billion. Mool also listed a 26.8 percent EBITDA margin and INR 23.10 billion of net debt for fiscal year 2026.

Price sits near the yearly low

The NSE quote ranged from INR 842.30 to INR 865.40 on October 16, 2026, leaving the stock 0.47 percent above its INR 842.05 52-week low and 30.84 percent below its INR 1,221.90 high. Trading volume was 4,034,401 shares against an average of 2,263,528 shares.

Max Health's valuation remained elevated within the hospital group. Its P/E ratio was 56.74 and its market capitalization was INR 823.4 billion on October 16, 2026. Prabhudas Lilladher retained a BUY rating and an INR 1,150 target in its August 16, 2026 report, while its Q1 fiscal year 2027 revenue of INR 28.35 billion was 4.3 percent above its estimate of INR 27.19 billion, according to DSIJ.

Comparison with peers

Max Health (NSE, INR): minus 1.40 percent, P/E 56.74, market capitalization INR 823.4 billion

Fortis Healthcare (NSE, INR): minus 1.31 percent, P/E 53.06, market capitalization INR 556.0 billion

Global Health (NSE, INR): minus 2.78 percent, P/E 59.96, market capitalization INR 333.4 billion

October 30 results set the next test

The scheduled October 30, 2026 results will give investors the next reported period against the fiscal year 2026 base. The combination of a 56.74 P/E ratio and a position 0.47 percent above the yearly low leaves the upcoming revenue and margin figures as the next concrete valuation reference.

Max Health was at INR 846.00 on the NSE on October 16, 2026 at 3:29 p.m. IST, down 1.40 percent versus the NSE prior close of INR 858.00.